Dermatology

A Wealth of Experience

We have collaborated with our clients on projects to research cutaneous diseases, cutaneous treatment, and complications and comorbidities of cutaneous disease.  Our experience includes:  

  • Acne
  • Alopecia
  • Atopic dermatitis
  • Dry skin
  • Eczema
  • Herpes
  • Psoriasis
  • Skin cancer
    • Basal cell carcinoma
    • Squamous cell carcinoma
    • Melanoma
  • Stevens-Johnson syndrome
  • Systemic lupus erythematosus
  • Toxic epidermal necrolysis
  • Warts

Types of Projects

We have implemented studies to help our clients develop strategies in the dermatology market and to develop and gain 
market access for products to treat cutaneous diseases and complications arising from treatment of cutaneous illnesses. 

Recent projects have included:

Our Experts

Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
T. Michelle Brown
Senior Director, Patient-Centered Outcomes Assessment
Dawn Odom
Vice President, Biostatistics
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Mary Anthony
Senior Director, Epidemiology
Marci Clark
Director, Patient-Centered Outcomes Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Margaret Mordin
Executive Director, Market Access and Outcomes Strategy
Daniel Mines
Senior Director, Epidemiology
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Sorrel Wolowacz
Head, European Health Economics
Katherine Stull
Director, Health Economics
James Twiss
Senior Research Scientist, Patient-Centered Outcomes Assessment
Josephine Mauskopf
Vice President, Health Economics
Dee Dee Mladsi
Head, Health Economics—Strategy and Early Modeling
William L Herring
Senior Director, Health Economics
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Xiaolei Zhou
Director, Biostatistics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Caroline Ling
Senior Director and HTA Specialist, Market Access and Outcomes Strategy
Diane Whalley
Executive Director, Patient-Centered Outcomes Assessment
Chris Knight
Senior Director, Health Economics
Kelly Hollis
Vice President, Surveys and Observational Studies
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Elena Rivero
Senior Director, Epidemiology
Mark Price
Executive Director, Surveys and Observational Studies
Ari Gnanasakthy
Principal Scientist, Patient-Centered Outcomes Assessment
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Patricia Sacco
Executive Director, Surveys and Observational Studies

Selected Recent Dermatology Publications

Arana A, Pottegard A, Kuiper JG, Crellin E, Reutfors J, Schmitt-Egenolf M, Lund LC, Houben E, Booth H, Calingaert B, Kaye JA, Gembert K, Rothman KJ, Dedman D, Kieler H, Gutierrez L, Hallas J, Perez-Gutthann S. To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Long-term results from Joelle Study. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.